Where do we stand with respect to the use of peripheral blood progenitor cells?
- 1 November 1994
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 5 (9) , 781-784
- https://doi.org/10.1093/oxfordjournals.annonc.a059003
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: Effect of graft sizeAnnals of Oncology, 1994
- Bone marrow transplants from peripheral bloodBMJ, 1994
- Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1lo Lin-Sca-1+ hematopoietic stem cellsBlood, 1994
- Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplantsBlood, 1994
- Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemiaBlood, 1992
- Separation of pluripotent haematopoietic stem cells from spleen colony-forming cellsNature, 1990
- GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATIONThe Lancet, 1989
- Two phases of engraftment established by serial bone marrow transplantation in miceBlood, 1989
- Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphomaBlood, 1986
- Circulating autologous stem cells collected in very early remission from acute non‐lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapyBritish Journal of Haematology, 1985